$MBRX Cashflow Statement | Understand Stock

$MBRX

$8.75 -$0.52 (5.61%) Close

$MBRX Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization
Stock-based compensation
Loss from sale of fixed assets
License rights expense settled in stock
Change in fair value of warrant liabilities
Loss on issuance of warrant liabilities
Transaction costs allocated to warrant liabilities
Loss on extinguishment of warrant liabilities
Operating lease, net

Changes in operating assets and liabilities:
Prepaid expenses and other assets
Accounts payable
Accrued expenses and other liabilities
Net cash used in operating activities
Cash flows from investing activities:
Purchase of fixed assets
Proceeds from sale of fixed assets
Net cash used in investing activities

Cash flows from financing activities:
Proceeds from sale of common stock, pre-funded and common warrants and warrant inducement, net of issuance and transaction costs
Proceeds from exercise of warrants
Payment of tax liability for vested restricted stock units
Proceeds from sale of common stock, net of issuance costs
Proceeds from sale of common stock, pre-funded and common warrants, net of issuance costs
Net cash provided by financing activities
Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents, at beginning of year
Cash and cash equivalents, at end of year

Effect of exchange rate changes on cash and cash equivalents
Supplemental disclosures of cash flow information:
Cash paid for interest
Cash paid for taxes

Non-cash investing and financing activities:
Reclassification of warrant liabilities to equity pursuant to warrant amendments
Equity warrants issued in relation to liability-classified warrant inducements
Offering costs included in accounts payable and accrued liabilities
Issuance of common stock to acquire license rights
Deemed dividend in connection with warrant amendment
Transaction costs related to the sale of common stock, pre-funded and common warrants
Purchases of property and equipment in accounts payable and accrued liabilities
Subscription receivable

Comments